Provided by Tiger Fintech (Singapore) Pte. Ltd.

RAPT Therapeutics, Inc.

10.72
+0.40003.88%
Post-market: 10.720.00000.00%16:10 EDT
Volume:45.87K
Turnover:484.12K
Market Cap:177.29M
PE:-1.63
High:11.13
Open:10.23
Low:10.06
Close:10.32
52wk High:26.56
52wk Low:5.67
Shares:16.54M
Float Shares:6.19M
Volume Ratio:0.46
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.5969
EPS(LYR):-25.4880
ROE:-77.83%
ROA:-46.24%
PB:1.08
PE(LYR):-0.42

Loading ...

Rapt Therapeutics Is Maintained at Neutral by UBS

Dow Jones
·
Aug 12

UBS Adjusts Price Target on RAPT Therapeutics to $9 From $8, Maintains Neutral Rating

MT Newswires Live
·
Aug 12

J.P. Morgan Remains a Hold on RAPT Therapeutics (RAPT)

TIPRANKS
·
Aug 09

RAPT Therapeutics Reports Q2 2025 Financial Results

TIPRANKS
·
Aug 08

RAPT Therapeutics’ RPT904: A Promising Catalyst with Competitive Edge in the Anti-IgE Market

TIPRANKS
·
Aug 07

RAPT Therapeutics Q2 EPS $(0.65) Misses $(0.63) Estimate

Benzinga
·
Aug 07

RAPT Therapeutics Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
Aug 04

RAPT Therapeutics Shares Rise After JPMorgan Upgrade

MT Newswires Live
·
Jul 31

JPMorgan Upgrades RAPT Therapeutics to Neutral From Underweight, Price Target is $14

MT Newswires Live
·
Jul 30

RAPT Therapeutics (RAPT) was upgraded to a Hold Rating at J.P. Morgan

TIPRANKS
·
Jul 30

U.S. RESEARCH ROUNDUP-Penumbra, UnitedHealth, Visa

Reuters
·
Jul 30

RAPT Therapeutics trading halted, volatility trading pause

TIPRANKS
·
Jul 15

Rapt Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Ashley L. Dombkowski

Reuters
·
Jul 01

RAPT Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Scott Braunstein

Reuters
·
Jun 25

Rapt Therapeutics appoints Scott Braunstein, Ashley Dombkowski to board

TIPRANKS
·
Jun 24

Press Release: RAPT Therapeutics Names Two Industry Veterans to its Board of Directors

Dow Jones
·
Jun 23

Rapt Therapeutics Announces 1-for-8 Reverse Stock Split Effective June 16, 2025

Reuters
·
Jun 18

RAPT Therapeutics trading halted, news pending

TIPRANKS
·
Jun 17

RAPT Therapeutics Announces 1-for-8 Reverse Stock Split Effective June 16, 2025

Reuters
·
Jun 13

RAPT Therapeutics Announces Development Plans for RPT904

TIPRANKS
·
Jun 10